Inventor · disambiguated record
Glen Macdonald
Also filed as: MACDONALD GLEN · MACDONALD GLEN C · MACDONALD GLEN CHRISTOPHER
16 granted patents·6 pending applications·51 citations·filing 2001–2016
91Inventor score
Files withVIVENTIA BIO INC8CIZEAU JEANNICK3MERCK PATENT GMBH3GLOVER NICHOLAS RONALD2VIVENTIA BIOTECHNOLOGIES INC2
Top patents by PatentIndex Score
22 records- 0188US7339031B2Modified bouganin proteins, cytotoxins and methods and uses thereofMERCK PATENT GMBH·Filed 2005·Granted Mar 4, 2008·11 cites·19 claims
- 0286US8383117B2CD44E tumor specific antibodyVIVENTIA BIOTECHNOLOGIES INC·Filed 2005·Granted Feb 26, 2013·12 cites·21 claims
- 0386US7956162B2Cancer-associated antigenVIVENTIA BIOTECHNOLOGIES INC·Filed 2006·Granted Jun 7, 2011·5 cites·3 claims
- 0483US8946390B2Cancer-associated antigenVIVENTIA BIO INC·Filed 2013·Granted Feb 3, 2015·2 cites·11 claims
- 0582US8263744B2Binding proteins that bind to EpCAM linked to an effector moleculeCIZEAU JEANNICK·Filed 2008·Granted Sep 11, 2012·5 cites·8 claims
- 0681US7750136B2Modified bouganin proteins, cytotoxins and methods and uses thereofMERCK PATENT GMBH·Filed 2008·Granted Jul 6, 2010·4 cites·16 claims
- 0780US8389286B2Cancer-associated antigenCHAHAL FRANCINA C·Filed 2011·Granted Mar 5, 2013·2 cites·4 claims
- 0878US8318472B2Optimized nucleic acid sequences for the expression of VB4-845CIZEAU JEANNICK·Filed 2008·Granted Nov 27, 2012·4 cites·26 claims
- 0971US9822182B2Anti-EPCAM antibodies and methods of useVIVENTIA BIO INC·Filed 2014·Granted Nov 21, 2017·3 cites·29 claims
- 1069US8716234B2Cytotoxins comprising modified bouganin toxin for the treatment of cancerBAKER MATTHEW·Filed 2010·Granted May 6, 2014·1 cites·10 claims
- 1166US8084576B2Cancer associated glucose transporter 8 variantGLOVER NICHOLAS RONALD·Filed 2005·Granted Dec 27, 2011·2 cites·7 claims
- 1263US2015297697A1Cancer-associated antigen related applicationsVIVENTIA BIO INC·Filed 2014·Application pending·0 cites
- 1359US2015018526A1Cytotoxins comprising modified bouganin toxin for the treatment of cancerMERCK PATENT GMBH·Filed 2014·Application pending·0 cites
- 1458US8969540B2Tumor specific antibodyVIVENTIA BIO INC·Filed 2013·Granted Mar 3, 2015·0 cites·16 claims
- 1557US2010215670A1Immunotoxin Fusions Comprising An Antibody Fragment and a Plant Toxin Linked by Protease Cleavable LinkersCIZEAU JEANNICK·Filed 2007·Application pending·0 cites
- 1652US8697075B2Cancer specific antibody and cell surface proteinsGLOVER NICHOLAS RONALD·Filed 2011·Granted Apr 15, 2014·0 cites·24 claims
- 1744US10576163B2Methods of treatment for EpCAM positive bladder cancerVIVENTIA BIO INC·Filed 2016·Granted Mar 3, 2020·0 cites·11 claims
- 1844US2015197575A1Tumor specific antibodyVIVENTIA BIO INC·Filed 2015·Application pending·0 cites
- 1944US2016060352A1Compositions and methods for detection and treatment of hepatocellular carcinomaVIVENTIA BIO INC·Filed 2014·Application pending·0 cites
- 2041US9109223B2Methods for generating and screening fusion protein libraries and uses thereofSCHWARTZ MITTELMAN ADRIAN·Filed 2006·Granted Aug 18, 2015·0 cites·11 claims
- 2135US10583198B2Dosing strategies for targeting EPCAM positive bladder cancerVIVENTIA BIO INC·Filed 2016·Granted Mar 10, 2020·0 cites·17 claims
- 2235US2002149253A1Novel seating apparatusFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Glen Macdonald files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →